glp 1 drugs shortage FDA Ends Compounding of GLP-1 as Shortages Improve, The U.S. Food and Drug Administration (FDA) has announced the end of the for GLP-1 weight loss drugs like Ozempic, leading to the What Changed? The FDA's Clarification

The two drugs are also competing head to head in obesity, where Novo Nordisk sells its drug as Wegovy and Lilly's is called Zepbound

Preclinical research and a small clinical study indicate CoQ10 supplementation may help improve cardiac performance in those with hyperthyroidism

Eight normal tissue samples were obtained from the adjacent non-tumorous tissues of patients who had undergone radical renal resection (mean age 59.9 6.1 years

This premium amino acid is vital for metabolism, helping to transport fatty acids into your cells to be converted into fuel

Retailers have also begun adjusting to meet the needs of these customers, including changing up ready meal offerings to increase protein and vegetables, stocking more on-the-go protein enhanced beverages, and highlighting products to help with side effects (e.g., gum to help with nausea) (Kendall, 2025